A new clinical study shows a cancer immunotherapy targeting PD-1 may enhance immune responses in people with HIV, reducing ...

More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

The 21-valent pneumococcal conjugate vaccine V116 is well tolerated in adults living with HIV and induces immunity to all 21 ...

In 2006 immunologist and 2025 Nobel prize winner Shimon Sakaguchi co-wrote an article in Scientific American that now feels ...

Nobel laureate Shimon Sakaguchi reflects on the role of regulatory T cells in peripheral immune tolerance and how the cells ...

The adult-specific 21-valent pneumococcal conjugate vaccine was well tolerated and immunogenic across all 21 serotypes in patients with HIV infection.

The world just took its biggest swing yet at ending the HIV epidemic. It’s not a cure, but it’s the next best thing: a shot.

It's very unlikely to get HIV from kissing. Here's how HIV can be transmitted and tips to prevent the spread.

Timothy Ray Brown, the first person known to be cured of HIV when he had a unique type of bone marrow transplant, has died in California after relapsing with cancer, his partner said.

Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defense and antiviral drugs by becoming "latent ...

The grants were awarded under the EMBODY program, which is supporting development of in vivo cell therapy delivery platforms.